Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus.

Autor: Raza H; Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan., Bhutta ME; Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan., Siddique MH; Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan.
Jazyk: angličtina
Zdroj: Sultan Qaboos University medical journal [Sultan Qaboos Univ Med J] 2024 Aug; Vol. 24 (3), pp. 418-419. Date of Electronic Publication: 2024 Aug 29.
DOI: 10.18295/squmj.8.2024.050
Databáze: MEDLINE